Corus Pharma

Developer of therapeutics for severe respiratory diseases. Its lead candidate Corus 1020 is an inhalable form of aztreonam (antibiotic) to treat respiratory infections. Other products include Corus 1030, an inhaled lidocaine for the treatment of asthma.